Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells
- 8 February 2010
- journal article
- Published by Springer Science and Business Media LLC in Cellular & Molecular Immunology
- Vol. 7 (2), 123-132
- https://doi.org/10.1038/cmi.2010.1
Abstract
Epigallocatechin-3-gallate (EGCG), a bioactive component of green tea, has been reported to exert anti-inflammatory effects on immune cells. EGCG is also shown to activate the metabolic regulator, adenosine 5'-monophosphate-activated protein kinase (AMPK). Reports have also indicated that EGCG inhibits the immune-stimulated phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway. The PI3K/Akt/mTOR pathway has been implicated in mesangial cell activation in lupus. Mesangial cells from MRL/lpr lupus-like mice are hyper-responsive to immune stimulation and overproduce nitric oxide (NO) and other inflammatory mediators when stimulated. In our current studies, we sought to determine the mechanism by which EGCG attenuates immune-induced expression of pro-inflammatory mediators. Cultured mesangial cells from MRL/lpr mice were pre-treated with various concentrations of EGCG and stimulated with lipopolysaccharide (LPS)/interferon (IFN)-gamma. EGCG activated AMPK and blocked LPS/IFN-gamma-induced inflammatory mediator production (iNOS expression, supernatant NO and interleukin-6). Interestingly, EGCG attenuated inflammation during AMPK inhibition indicating that the anti-inflammatory effect of EGCG may be partially independent of AMPK activation. Furthermore, we found that EGCG effectively inhibited the immune-stimulated PI3K/Akt/mTOR pathway independently of AMPK, by decreasing phosphorylation of Akt, suggesting an alternate mechanism for EGCG-mediated anti-inflammatory action in mesangial cells. Taken together, these studies show that EGCG attenuated inflammation in MRL/lpr mouse mesangial cells via the PI3K/Akt/mTOR pathway. Our findings suggest a potential therapeutic role for the use of EGCG to regulate inflammation and control autoimmune disease.Keywords
This publication has 83 references indexed in Scilit:
- Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cellsClinical and Experimental Immunology, 2009
- Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Differential Effects of Rapamycin in Anti-GBM GlomerulonephritisJournal of the American Society of Nephrology, 2008
- Epigallocatechin-3-O-gallate inhibits TNFα-induced monocyte chemotactic protein-1 production from vascular endothelial cellsLife Sciences, 2008
- Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/AktJournal of Neuroinflammation, 2008
- Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritisArthritis Research & Therapy, 2008
- Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritisArthritis & Rheumatism, 2007
- Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through 5′-AMP-activated Protein KinaseOnline Journal of Public Health Informatics, 2007
- Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupusJCI Insight, 2007
- A Proteomic Screen Identified Stress-Induced Chaperone Proteins as Targets of Akt Phosphorylation in Mesangial CellsJournal of Proteome Research, 2006